Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia

BMC Public Health

Abraham Aseffa²  Fikre Enquselassie¹  Gebretsadik Berhe³ 

[1] School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia;Armauer Hansen Research Institute, Addis Ababa, Ethiopia;College of Veterinary Medicine, Mekelle University, Mekelle, Ethiopia

关键词: Ethiopia;    Tigray;    Pulmonary tuberculosis;    Treatment outcome;    Smear-positive;   

Others  :  1163438
DOI  :  10.1186/1471-2458-12-537

 received in 2011-12-20, accepted in 2012-07-10,  发布年份 2012

【 摘 要 】

Background

Monitoring the outcome of tuberculosis treatment and understanding the specific reasons for unsuccessful treatment outcome are important in evaluating the effectiveness of tuberculosis control program. This study investigated tuberculosis treatment outcomes and predictors for unsuccessful treatment outcome in the Tigray region of Ethiopia.

Methods

Medical records of smear-positive pulmonary tuberculosis (PTB) patients registered from September 2009 to June 2011 in 15 districts of Tigray region, Northern Ethiopia, were reviewed. Additional data were collected using a structured questionnaire administered through house-to-house visits by trained nurses. Tuberculosis treatment outcomes were assessed according to WHO guidelines. The association of unsuccessful treatment outcome with socio-demographic and clinical factors was analyzed using logistic regression model.

Results

Out of the 407 PTB patients (221 males and 186 females) aged 15 years and above, 89.2% had successful and 10.8% had unsuccessful treatment outcome. In the final multivariate logistic model, the odds of unsuccessful treatment outcome was higher among patients older than 40 years of age (adj. OR = 2.50, 95% CI: 1.12-5.59), family size greater than 5 persons (adj. OR = 3.26, 95% CI: 1.43-7.44), unemployed (adj. OR = 3.10, 95% CI: 1.33-7.24) and among retreatment cases (adj. OR = 2.00, 95% CI: 1.37-2.92) as compared to their respective comparison groups.

Conclusions

Treatment outcome among smear-positive PTB patients was satisfactory in the Tigray region of Ethiopia. Nonetheless, those patients at high risk of an unfavorable treatment outcome should be identified early and given additional follow-up and social support.

【 授权许可】

   
2012 Berhe et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]World Health Organization: Global Tuberculosis Control. Geneva: World Health Organization; 2011.
• [2]World Health Organization: Forty-fourth World Health Assembly. Geneva: World Health Organization; 1991. http://www.wpro.who.int/NR/rdonlyres/2DDF1ABF-8ACC-496F-B936-ED01F81ACC0C/0/WHA445.pdf webcite
• [3]Raviglione MC, Pio A: Evolution of WHO policies for tuberculosis control, 1948–2001. Lancet 2002, 359:775-780. http://rih.stanford.edu/week%204/Raviglione%20-%20WHO%20Policies%20for%20TB%20Control.pdf webcite
• [4]Lönroth K, Raviglione M: Global epidemiology of tuberculosis: Prospects for control. Semin Respir Crit Care Med 2008, 29:481-491. http://www.uptodate.com/contents/epidemiology-of-tuberculosis/abstract/2?utdPopup=true webcite
• [5]World Health Organization: Global Tuberculosis Control. Geneva: World Health Organization; 2009. http://whqlibdoc.who.int/publications/2009/9789241563802_eng_doc.pdf webcite
• [6]: The global plan to stop TB, 2011–2015/Stop TB Partnership: Transforming the fight towards elimination of tuberculosis. Geneva: World Health Organization; 2010. http://www.stoptb.org/assets/documents/global/plan/TB_GlobalPlanToStopTB2011-2015.pdf webcite
• [7]Ministry of Health of Ethiopia: Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme Manual. Addis Ababa: MOH. 4th edition. 2008.
• [8]Federal Ministry of Health: Overview of National TB Control Implementation status. Gondar, Ethiopia: Sixth National TB Research Workshop, Gondar University, 6–8 June 2011; 2011.
• [9]Mengiste MM: Community-Based Directly Observed Treatment Short course strategy in pilot districts of Tigray: Overview of baseline studies. Ethiop J Health Dev 2005, 19(Special Issue):3-6.
• [10]Tigray Health Bureau: nnual TB performance report in Tigray region. Gondar, Ethiopia: Sixth National TB Research Workshop, Gondar University, 6–8 June 2011; 2011.
• [11]Mengiste MM, Tesfay WT, Madeley JR: The quality of tuberculosis diagnosis in districts of Tigray region of northern Ethiopia. Ethiop J Health Dev 2005, 19(Special Issue):13-20. http://ejhd.uib.no/ejhd19-special%20issue%20tuberculosis/13.%20The%20quality%20of%20tuberculosis%20diagnosis.pdf webcite
• [12]Veen J, Raviglione M, Rieder HL, Migliori GB, Graf P, Grzemska M, Zalesky R: Standardized tuberculosis treatment outcome monitoring in Europe. Working Group Recommendations. Eur Respir J 1998, 12:505-510. http://erj.ersjournals.com/content/12/2/505.long webcite
• [13]Tuula V, Pekka H, Jukka O, Kari L, Maarit K, Petri R: Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. BMC Public Health 2007, 7:291-299. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2099439/ webcite]
• [14]Muñoz-Sellart M, Cuevas LE, Tumato M, Merid Y, Yassin MA: Factors associated with poor tuberculosis treatment outcome in the Southern Region of Ethiopia. INT J TUBERC LUNG DIS 2010, 14(8):973-979. http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/68394092.1/iuatld/ijtld/2010/00000014/00000008/art00010/0A6CFC6683126EB713349018795BE67560E71A5D76.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf webcite
• [15]Tessema B, Muche A, Bekele A, Reissig D, Emmrich F, Sack U: Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five - year retrospective study. BMC Public Health 2009, 9:371-378. http://www.biomedcentral.com/1471-2458/9/371 webcite
• [16]Shargie EB, Lindtjørn B: Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in southern Ethiopia. PLoS Med 2007, 4(2):e37. http://ukpmc.ac.uk/articles/1796905?pdf=render webcite
• [17]Tekle B, Mariam DH, Ali A: Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int J Tuberc Lung Dis 2002, 6(7):573-579. http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/68394173.1/iuatld/ijtld/2002/00000006/00000007/art00005/A4F5F407D1E7E4671334902433145D52BA268CA00A.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf webcite
• [18]Getahun B, Ameni G, Biadgilign S, Medhin G: Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTS programme in Addis Ababa, Ethiopia. BMC Infectious Diseases 2011, 11:127-134. http://www.biomedcentral.com/1471-2334/11/127 webcite
• [19]Rieder HL: Sputum smear-conversion during directly observed treatment for tuberculosis. Tubercle Lung Dis 1996, 77:124-129.
• [20]Liippo KK, Kulmala K, Tala EOJ: Focusing tuberculosis contact tracing by smear grading of index cases. Am Rev Respir Dis 1993, 148:235-236.
• [21]Veen J, Raviglione M, Rieder HL, Migliori GB, Graf P, Grzemska M, Zalesky R: Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J 1998, 12:505-510. http://erj.ersjournals.com/content/12/2/505.long webcite
• [22]Datiko DG, Lindtjørn B: Health Extension Workers Improve Tuberculosis Case Detection and Treatment Success in Southern Ethiopia: A Community Randomized Trial. PLoS ONE 2009, 4(5):e5443. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0005443 webcite
• [23]van den Boogaard J, Lyimo R, Irongo CF, Boeree MJ, Schaalma H, Aarnoutse RE, Kibiki GS: Community vs. facility-based directly observed treatment for tuberculosis in Tanzania's Kilimanjaro Region. Int J Tuberc Lung Dis 2009, 13(12)):1524-1529. http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/68394300.1/iuatld/ijtld/2009/00000013/00000012/art00014/941DFC571995AB8A1334903092386248F6C455AA29.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf webcite
• [24]Gelaw M, Genebo T, Dejene A, Lemma E, Eyob G: Attitude and social consequences of tuberculosis in Addis Ababa, Ethiopia. East Afr Med J 2001, 78:382-388.
• [25]Fatiregun AA, Ojo AS, Bamgboye AE: Treatment outcomes among pulmonary tuberculosis patients at treatment centers in Ibadan, Nigeria. Ann Afr Med 2009, 8:100-104. http://www.annalsafrmed.org/text.asp?2009/8/2/100/56237 webcite
• [26]Harries AD, Nyirenda TE, Banerjee A, Boeree MJ, Salaniponi FM: Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi. Trans R Soc Trop Med Hyg. 1999, 93(4):443-446.
• [27]Talay F, Kumbetli S, Altin S: Factors associated with treatment success for tuberculosis patients: a single center's experience in Turkey. Jpn J Infect Dis 2008, 61(1):25-30. http://www.ncbi.nlm.nih.gov/pubmed/18219130 webcite
• [28]Nik Nor Ronaidi NM, Mohd NS, Wan Mohammad Z, Sharina D, Nik Rosmawati NH: Factors associated with unsuccessful treatment outcome of Pulmonary tuberculosis in kota Bharu, kelantan. Malaysian Journal of Public Health Medicine 2011, 11(1):6-15. http://www.pppkam.org.my/mjphm/journals/Volume%2011:1/174-11-TO%20PUBLISH.pdf webcite
• [29]Anunnatsiri S, Chetchotisakd P, Wanke C: Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand. Southeast Asian J Trop Med Public Health 2005, 36(2):324-30.
• [30]Farah MG, Tverdal A, Steen TW, Heldal E, Brantsaeter AB, Bjune G: Treatment outcome of new culture positive pulmonary tuberculosis in Norway. BMC Public Health 2005, 5:14-20. http://www.biomedcentral.com/content/pdf/1471-2458-5-14.pdf webcite
• [31]Jyh Lee JJ, Wu RL, Lee YS, Wu YC, Chiang CY: Treatment Outcome of Pulmonary Tuberculosis in Eastern Taiwan—Experience at a Medical Center. J Formos Med Assoc 2007, 106:25-30. http://www.sciencedirect.com/science/article/pii/S0929664609602126 webcite
• [32]Zellweger JP, Coulon P: Outcome of patients treated for tuberculosis in Vaud County, Switzerland. Int J Tuberc Lung Dis 1998, 2:372-377. http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/68394386.1/iuatld/ijtld/1998/00000002/00000005/art00004/55ADBEF68F7355251334903523B36D2439624C3C51.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf webcite
• [33]Cayla JA, Caminero JA, Rey R, Lara N, Valles X, Galdos-Tanguis H: Working Group on Completion of Tuberculosis Treatment in Spain: Current status of treatment completion and fatality among tuberculosis patients in Spain. Int J Tuberc Lung Dis 2004, 8:458-464. http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/68394416.1/iuatld/ijtld/2004/00000008/00000004/art00012/4EA0C3B19C2462CF1334903659B3A7F76CC8977DB6.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf webcite
• [34]Falzon D, Le Strat Y, Belghiti F, Infuso A: Euro TB Correspondents: Exploring the determinants of treatment success for tuberculosis cases in Europe. Int J Tuberc Lung Dis 2005, 9:1224-1229. http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/68394431.1/iuatld/ijtld/2005/00000009/00000011/art00009/78F487B6410B228C1334903769A2AE38319821DDF4.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf webcite
• [35]de Albuquerque MF, Ximenes RA, Lucena- Silva N, et al.: Factors associated with treatment failure, dropout, and death in a cohort of tuberculosis patients in Recife, Pernambuco State, Brazil. Cad Saude Publica 2007, 23(7):1573-82. http://www.scielosp.org/pdf/csp/v23n7/08.pdf webcite
• [36]Vijay S, Kumar P, Chauhan LS, Narayan Rao SV, Vaidyanathan P: Treatment Outcome and Mortality at One and Half Year Follow-Up of HIV Infected TB Patients Under TB Control Programme in a District of South India. PLoS ONE 2011, 6(7):e21008. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0021008 webcite
• [37]Alpert PL, Munsiff SS, Gourevitch MN, Greenberg B, Klein RS: A prospective study of tuberculosis and HIV, clinical manifestations and factors associated with survival. Clin Infect dis 1997, 24:661-668. http://cid.oxfordjournals.org/content/24/4/661.long webcite
• [38]Tekkel M, Rahu M, Loit HM, Baburin A: Risk factors for pulmonary tuberculosis in Estonia. Int J Tuberc Lung Dis 2002, 6(10):887-94. http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/68394532.1/iuatld/ijtld/2002/00000006/00000010/art00007/588C29D9FCB56FC91334904286B5B5ADD934AFFAED.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf webcite
• [39]Belo MTC, Luiz RR, Teixeira EG, Hanson C, Trajman A: Tuberculosis treatment outcomes and socio-economic status: a prospective study in Duque de Caxias, Brazil. INT J TUBERC LUNG DIS 2011, 15(7):978-981. http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/68394580.1/iuatld/ijtld/2011/00000015/00000007/art00021/CBCE66536D4801B1133490450503561A51CE0C6DE1.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf webcite
• [40]Ekaterina B, Ajeilat S, Dadu A, Aitmagambetova I, Ershova J, Fagan R, Favorov MO: Progress Toward Tuberculosis Control and Determinants of Treatment Outcomes --- Kazakhstan, 2000—2002. MMWR 2006, 55(SUP01):11-15. http://www.cdc.gov/mmwr/preview/mmwrhtml/su5501a4.htm webcite
• [41]Szczuka I: Cohort analysis for treatment outcomes TB pulmonary cases bacteriologically confirmed in Poland. Pneumonol Alergol Pol 2005, 73(3):245-53. http://www.ncbi.nlm.nih.gov/pubmed/16989161 webcite
• [42]World Health Organization: Global tuberculosis control 2008. Surveillance, planning, fi nancing. WHO report 2008. WHO/HTM/TB/2008.393. Geneva, Switzerland: WHO; 2008.
• [43]Parry E, Godfrey R, Mabey S, Gill G: Principles of medicine in Africa. 3rd edition. Cambridge, UK: Cambridge University Press; 2004.
• [44]Yassin MA, Takele L, Gebresenbet S, et al.: HIV and tuberculosis coinfection in the southern region of Ethiopia: a prospective epidemiological study. Scand J Infect Dis 2004, 36:670-673. http://informahealthcare.com/doi/abs/10.1080/00365540410020848 webcite
• [45]Mitike G, Kebede D, Yeneneh H: HIV infection and anti tuberculosis drug resistance among pulmonary TB patients in Harar Tuberculosis Center, Ethiopia. East Afr Med J 1997, 74:154-157. http://www.ncbi.nlm.nih.gov/pubmed/9185411 webcite